CY1124656T1 - Νανο-εναιωρημα φυσικων υλικων και μεθοδος παρασκευης αυτου - Google Patents

Νανο-εναιωρημα φυσικων υλικων και μεθοδος παρασκευης αυτου

Info

Publication number
CY1124656T1
CY1124656T1 CY20211100862T CY211100862T CY1124656T1 CY 1124656 T1 CY1124656 T1 CY 1124656T1 CY 20211100862 T CY20211100862 T CY 20211100862T CY 211100862 T CY211100862 T CY 211100862T CY 1124656 T1 CY1124656 T1 CY 1124656T1
Authority
CY
Cyprus
Prior art keywords
nano
suspension
preparation
natural materials
natural material
Prior art date
Application number
CY20211100862T
Other languages
English (en)
Inventor
Werner Brand
Original Assignee
Apurano Pharmaceuticals Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Apurano Pharmaceuticals Gmbh filed Critical Apurano Pharmaceuticals Gmbh
Publication of CY1124656T1 publication Critical patent/CY1124656T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/03—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/748—Cyanobacteria, i.e. blue-green bacteria or blue-green algae, e.g. spirulina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/20—Ingredients acting on or related to the structure
    • A23V2200/25—Nanoparticles, nanostructures

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Polymers & Plastics (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Η παρούσα αποκάλυψη αναφέρεται σε μία μέθοδο για την παρασκευή ενός νανο-εναιωρήματος τουλάχιστον ενός φυσικού υλικού, όπου η μέθοδος περιλαμβάνει τα βήματα (a) παροχής τουλάχιστον ενός φυσικού υλικού που έχει ένα μέγεθος σωματιδίων (D90) μικρότερο από 320 μm, (b) διασποράς του εν λόγω ενός φυσικού υλικού του βήματος (a) σε ένα διαλύτη, και (c) λειοτρίβησης της διασποράς του βήματος (b) έως ένα μέγεθος σωματιδίων (D90) κάτω από 1000 nm. To νανο-εναιώρημα είναι χρήσιμο για την παρασκευή ενός φαρμάκου.
CY20211100862T 2014-02-03 2021-10-05 Νανο-εναιωρημα φυσικων υλικων και μεθοδος παρασκευης αυτου CY1124656T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP14153705 2014-02-03
EP2014064449 2014-07-07
PCT/EP2015/052202 WO2015114164A1 (en) 2014-02-03 2015-02-03 Nanosuspension of natural materials and preparation method thereof

Publications (1)

Publication Number Publication Date
CY1124656T1 true CY1124656T1 (el) 2022-07-22

Family

ID=52444306

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20211100862T CY1124656T1 (el) 2014-02-03 2021-10-05 Νανο-εναιωρημα φυσικων υλικων και μεθοδος παρασκευης αυτου

Country Status (22)

Country Link
US (1) US10213382B2 (el)
EP (1) EP3102185B1 (el)
JP (2) JP6751672B2 (el)
KR (1) KR20160118317A (el)
CN (1) CN106102719A (el)
AU (1) AU2015212726B2 (el)
CA (1) CA2938552C (el)
CY (1) CY1124656T1 (el)
DK (1) DK3102185T3 (el)
ES (1) ES2891151T3 (el)
HR (1) HRP20211513T1 (el)
HU (1) HUE056398T2 (el)
LT (1) LT3102185T (el)
MX (1) MX2016010037A (el)
NZ (1) NZ723631A (el)
PL (1) PL3102185T3 (el)
RS (1) RS62381B1 (el)
RU (1) RU2695325C1 (el)
SA (1) SA516371597B1 (el)
SI (1) SI3102185T1 (el)
WO (1) WO2015114164A1 (el)
ZA (1) ZA201604743B (el)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI3102185T1 (sl) * 2014-02-03 2022-01-31 Apurano Pharmaceuticals Gmbh Nanosuspenzija naravnih materialov in postopek priprave le-te
CA2994620C (en) 2015-08-04 2021-07-06 Apurano Life Sciences Gmbh Nanosuspension containing particles and extract of natural materials
JP6664770B1 (ja) * 2018-03-27 2020-03-13 株式会社Ｍｉｚｋａｎ Ｈｏｌｄｉｎｇｓ 植物含有固体脂組成物、その製造方法及び外観・食味の改善方法
US20210138165A1 (en) * 2018-07-10 2021-05-13 Applied Lifesciences and Systems, LLC Systems and methods of preparing and delivering oocyst solutions
CN109432018A (zh) * 2018-12-25 2019-03-08 中国人民解放军第四军医大学 难溶性药物的纳米混悬液及其制备方法和应用
KR102116022B1 (ko) * 2019-07-16 2020-05-27 (주)코이즈 고농도의 산소를 함유하는 미세소구체가 포함된 화장료 조성물 및 이의 제조방법
ES2938493T3 (es) 2020-01-06 2023-04-11 Cannaxan Gmbh Preparación y uso de nanoformulación de cannabis
US11832614B1 (en) 2023-04-28 2023-12-05 King Faisal University Method of inhibiting mycotoxin growth using Arthrospira platensis nanoparticles

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3502153A1 (de) 1985-01-23 1986-07-24 Röben Kolloid Entwicklung GmbH & Co KG, 2932 Zetel Kolloidator zum kolloidieren von fliessfaehigen materialien
DE4137540A1 (de) 1991-11-14 1993-05-19 Steigerwald Arzneimittelwerk Verwendung von praeparaten der curcuma-pflanzen
JPH05221852A (ja) * 1992-02-18 1993-08-31 L T T Kenkyusho:Kk 制ガン剤の新規製剤調製方法
ZA9711731B (en) * 1996-12-31 1998-07-01 Monsanto Co Aqueous glycerol formulations of somatotropin
US20050107582A1 (en) 2003-07-30 2005-05-19 Alfred Wong Method for the preparation of phytosterols from tall oil pitch
US20120042886A1 (en) * 1998-03-11 2012-02-23 Hanna Piskorz Method of producing a nicotine medicament and a medicament made by the method
DE19832304A1 (de) * 1998-07-17 2000-01-20 Reiner Weichert Verfahren und Vorrichtung zur Ultrafein-Mahlung von festen Materialien
US6375986B1 (en) 2000-09-21 2002-04-23 Elan Pharma International Ltd. Solid dose nanoparticulate compositions comprising a synergistic combination of a polymeric surface stabilizer and dioctyl sodium sulfosuccinate
WO2001001962A1 (en) 1999-07-05 2001-01-11 Idea Ag. A method for the improvement of transport across adaptable semi-permeable barriers
TWI300714B (en) 2001-04-27 2008-09-11 Ajinomoto Kk Immunopotentiators
JP4752233B2 (ja) * 2001-04-27 2011-08-17 味の素株式会社 免疫賦活剤
JP2005508345A (ja) 2001-09-28 2005-03-31 グライコメッド・サイエンシーズ・リミテッド 溶媒抽出法
CN1416847A (zh) * 2001-11-07 2003-05-14 焦柏忠 纳米级西洋参制品及其制作方法
IL146737A (en) * 2001-11-26 2010-02-17 Lycored Natural Prod Ind Ltd Method for protecting lycopene dispersed in tomato fibers
EP1480661B1 (de) * 2002-02-28 2011-04-13 Heitland & Petre International GmbH Mikro-/nanopartikel aus lipidhaltigen marinen organismen für pharmazie und kosmetik
JP2005531606A (ja) * 2002-06-10 2005-10-20 エラン ファーマ インターナショナル，リミティド ナノ粒子ステロール製剤およびステロールの組合せ
US20120156309A1 (en) * 2007-09-19 2012-06-21 Eckert C Edward Using Aqueous Oxygenation to Improve Animal Health & Wellness
US20060062926A1 (en) * 2004-05-17 2006-03-23 Richardson H W Use of sub-micron copper salt particles in wood preservation
WO2006091780A2 (en) 2005-02-24 2006-08-31 Elan Pharma International Limited Nanoparticulate formulations of docetaxel and analogues thereof
DE102005011786A1 (de) * 2005-03-11 2006-09-14 Pharmasol Gmbh Verfahren zur Herstellung ultrafeiner Submicron-Suspensionen
CN100341785C (zh) * 2005-07-27 2007-10-10 湖州吴兴恒联碳酸钙厂 亚微米级重质碳酸钙的制备方法
CN101932416B (zh) * 2007-12-21 2013-12-04 三菱化学株式会社 纤维复合体
JP5374869B2 (ja) * 2007-12-25 2013-12-25 三菱化学株式会社 セルロース繊維複合体
WO2009116538A1 (ja) * 2008-03-17 2009-09-24 サントリーホールディングス株式会社 呈味改善剤及びこれを含む茶飲料
JP5448511B2 (ja) 2008-03-31 2014-03-19 三栄源エフ・エフ・アイ株式会社 ウコン色素組成物及びその調製方法
JP2010083839A (ja) * 2008-10-02 2010-04-15 Sanei Gen Ffi Inc ミルクカルシウムの分散安定化方法並びにその製剤
KR101160801B1 (ko) * 2010-05-27 2012-06-29 서용일 고형 보조 첨가제
EP2581092B2 (en) 2010-06-08 2020-03-11 Asahi Group Holdings, Ltd. Agent for improving lipid metabolism
TWI425914B (zh) * 2011-03-21 2014-02-11 Food Industry Res & Dev Inst 含高濃度奈米／次微米疏水性機能化合物之水相分散液之製備方法
US9278071B2 (en) * 2012-05-11 2016-03-08 Activus Pharma Co., Ltd. Organic compound nano-powder, method for producing the same and suspension
SI3102185T1 (sl) * 2014-02-03 2022-01-31 Apurano Pharmaceuticals Gmbh Nanosuspenzija naravnih materialov in postopek priprave le-te
JP6672258B2 (ja) * 2014-04-08 2020-03-25 フィリップ・モーリス・プロダクツ・ソシエテ・アノニム ニコチン製剤及びその作製方法

Also Published As

Publication number Publication date
SI3102185T1 (sl) 2022-01-31
NZ723631A (en) 2017-08-25
CA2938552C (en) 2021-07-13
ES2891151T3 (es) 2022-01-26
HRP20211513T1 (hr) 2021-12-24
ZA201604743B (en) 2017-09-27
CA2938552A1 (en) 2015-08-06
KR20160118317A (ko) 2016-10-11
RU2695325C1 (ru) 2019-07-23
HUE056398T2 (hu) 2022-02-28
AU2015212726A1 (en) 2016-09-15
WO2015114164A1 (en) 2015-08-06
CN106102719A (zh) 2016-11-09
EP3102185A1 (en) 2016-12-14
JP2017505814A (ja) 2017-02-23
PL3102185T3 (pl) 2021-12-27
JP2018172394A (ja) 2018-11-08
JP6751672B2 (ja) 2020-09-09
RS62381B1 (sr) 2021-10-29
EP3102185B1 (en) 2021-07-14
LT3102185T (lt) 2022-01-10
DK3102185T3 (da) 2021-10-04
AU2015212726B2 (en) 2018-02-01
US20160346201A1 (en) 2016-12-01
MX2016010037A (es) 2017-10-26
US10213382B2 (en) 2019-02-26
SA516371597B1 (ar) 2020-04-29

Similar Documents

Publication Publication Date Title
CY1124656T1 (el) Νανο-εναιωρημα φυσικων υλικων και μεθοδος παρασκευης αυτου
MA39883A (fr) Particules inorganiques individualisées
EP3511297A4 (en) MOSXOY / CARBON NANOMETER COMPOSITE, METHOD OF MANUFACTURING THEREOF AND USE THEREOF
EP3564341A4 (en) COMPOSITE MATERIAL WITH QUANTUM BOXES, PREPARATION METHOD, AND SEMICONDUCTOR DEVICE
EP3152346A4 (en) Large scale production of thinned graphite, graphene, and graphite-graphene composites
EP3479998A4 (en) HOT-MELT LAMINATING MATERIAL FOR 3D PRINTERS AND HOT-MELT LAMINATING THREAD FOR 3D PRINTERS THEREFOR
BR112016025291A2 (pt) conjugados de anticorpo anti-ptk7-fármaco
MX2017006257A (es) Producto tipo yogur basado en proteinas del suero lacteo, de alto contenido proteico, ingrediente adecuado para su produccion, y metodo de produccion.
IL266085A (en) New process for producing highly carbonaceous materials and the highly carbonaceous material obtained
AR087697A1 (es) Proceso para preparar suspensiones de particulas de pigmentos autoaglutinantes, suspensiones, articulo de papel y uso de las suspensiones
MX2015011529A (es) Reordenamiento del virus de infuenza b.
EP3228640A4 (en) Curable composition containing semiconductor nanoparticles, cured product, optical material and electronic material
CY1123956T1 (el) Φαρμακευτικη συνθεση, περιλαμβανουσα σωματιδια φωσφορικου συνδετικου
WO2016096085A8 (en) Particles for electrophoretic displays
EP3684727A4 (en) BORNITRIDE NANOTUBE (BNNT) NANOPARTICLE COMPOSITE MATERIALS, METHOD FOR MANUFACTURING THEREOF, AND THEIR MACROSCOPIC ARRANGEMENTS
AR096167A1 (es) Clasificador
EP3398921A4 (en) PROCESS FOR OBTAINING A CERAMIC BARBOTINE FOR THE MANUFACTURE OF 3D-FDM PRINTING WIRES, BARBOTINE OBTAINED THEREBY AND CERAMIC WIRES
CY1124180T1 (el) Κρυσταλλος 6-βρωμο-3-υδροξυ-2-πυραζινοκαρβοξαμιδιου και μεθοδος για τη παραγωγη αυτου
EP3470385A4 (en) SILICON CARBIDE MANUFACTURING METHOD AND SILICON CARBIDE COMPOSITE
EP3386916A4 (en) IMPROVEMENTS IN THE PRODUCTION OF SILICON NANOPARTICLES AND USES THEREOF
BR112017014083A2 (pt) artigos abrasivos e métodos para formar os mesmos
EP3402747A4 (en) COMPOSITES WITH ALIGNED CARBON NANOTONES, METHOD FOR THE PRODUCTION THEREOF AND APPLICATIONS THEREOF
BR112017016660A2 (pt) papel de base decorativa pré-impregnado para materiais de revestimento decorativo, método para produção e material de revestimento decorativo
WO2015147928A3 (en) Composite materials with magnetically aligned carbon nanoparticles and methods of preparation
EP3426876A4 (en) DEFORMABLE HOLE BACK STRUCTURES COMPRISING CARBON NANOTUBE MATERIALS AND METHODS OF FORMING AND USING SUCH STRUCTURES